The DOI matches its Crossref record.
Plasmapheresis in immunologically mediated polyneuropathies.
Abstract
Abstract: One of the most common uses of therapeutic plasmapheresis is for the treatment of immunologically mediated polyneuropathies. This paper discusses the use of plasmapheresis in Guillain‐Barré syndrome, chronic inflammatory demyelinating polyneuropathy, polyneuropathies associated with paraproteins, lower motor neuron syndromes, and polyneuropathies associated with HIV. As the pathogenesis of immunologically mediated polyneuropathies becomes better understood, newer therapies for these syndromes will evolve; however, therapeutic plasmapheresis is likely to continue to play a central role in the treatment of many of these diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
There is a procedure for human patients analogous to NBE, called Therapeutic Plasma Exchange (TPE), which is FDA approved and routinely used in the clinic.
“there is a procedure for human patients analogous to NBE, where most of the plasma is replaced by physiologic solution supplemented with commercial human albumin, called Therapeutic Plasma Exchange, TPE, which is FDA approved and routinely used in the clinic [16–18].”
From Rejuvenation of three germ layers tissues by exchanging old blood plasma with saline-albumin (2020) · cites this paper as [18]
Human blood samples were provided under an IRB approved by Sutter Health, without personal identifiers, and were not linked to or traced back to personal information.
“On shelf samples of human blood (collected through the FDA approved and routinely used in the clinic procedure of Therapeutic Plasma Exchange [16–18]) were provided to us by Dr. Dobri Kiprov (IRB Approved by Sutter health, 648823) without personal identifiers and were not linked to or traced back to any personal information in our study.”
From Rejuvenation of three germ layers tissues by exchanging old blood plasma with saline-albumin (2020) · cites this paper as [18]
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 73
- Pfaeffl W, 1986, Immune and Metabolic Aspects of Therapeutic Blood Purification Systems, 323
- KiprovD DauP MorandP.The effect of plasmapheresis and drug immunosuppression on T‐cell subsets as defined by monoclonal antibodies.J Clin Apher1983;1:57–63. · DOI
- KiprovD MillerR.Paraproteinemia associated with demyelinating polyneuropathy or myositis: Treatment with plasmapheresis and immunosuppressive drugs.Artif Organs1985;9:47–52. · DOI
- KiprovD MillerR.Polymyositis associated with monoclonal gammopathy.Lancet1984;2:1183–6. · DOI
- 10.1002/(SICI)1098-1101(2000)15:1/2<1::AID-JCA1>3.0.CO;2-R · DOI
- 10.1002/(SICI)1098-1101(2000)15:1/2<74::AID-JCA6>3.0.CO;2-O · DOI
- 10.1046/j.1526-0968.1999.00146.x · DOI
- KiprovD GoldenP RoheR SmithS HofmannJ HunnicuttJ.Adverse reactions associated with mobile therapeutic apheresis. Analysis of 17 940 procedures.J Clin Apher2001;16:130–3. · DOI · Paper page
- 10.1002/jca.2920010209 · DOI
- 10.1046/j.1537-2995.1999.39399219285.x · DOI
- 10.1038/2281304a0 · DOI
- Dau PC, 1991, Immunologic effects of plasmapheresis synchronized with pulse cyclophosphamide in systemic lupus erythematosus, J Rheumatol, 18, 270
- Ropper AH., 1992, The Guillain–Barré syndrome, N Engl J Med, 326, 1131
- 10.1056/NEJM195607122550201 · DOI
- Baldwin RT, 1992, Guillain–Barré syndrome after heart transplantation, J Heart Lung Transplant, 11, 817
- 10.1097/00019052-200210000-00015 · DOI
- 10.1097/00019052-200206000-00018 · DOI
- 10.1006/jaut.1999.0346 · DOI
- 10.1016/0022-510X(93)90304-H · DOI
- 10.1002/ana.410150209 · DOI
- 10.1212/WNL.32.10.1151-a · DOI
- 10.1073/pnas.82.3.905 · DOI
- 10.1002/ana.410350217 · DOI
- 10.1212/WNL.43.2.414 · DOI
- 10.1086/513793 · DOI
- 10.1084/jem.178.5.1771 · DOI
- 10.1016/S0140-6736(78)91837-8 · DOI
- 10.1111/j.1423-0410.1981.tb01017.x · DOI
- 10.1016/S0140-6736(84)91341-2 · DOI
- 10.1002/ana.410220612 · DOI
- 10.1212/WNL.35.8.1096 · DOI
- 10.1056/NEJM199204233261705 · DOI
- Plasma Exchange/Sandoglobulin Guillian–Barré Syndrome Trial Group., 1997, Randomized trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain–Barré syndrome, Lancet, 349, 225, 10.1016/S0140-6736(96)09095-2 · DOI
- 10.1212/WNL.43.5.1034 · DOI
- 10.1212/WNL.43.5.872 · DOI
- Guillain–Barré Syndrome Steroid Trial Group., 1993, Double‐blind trial of intravenous methylprednisolone in Guillain–Barré syndrome, Lancet, 341, 586
- 10.1002/ana.410380519 · DOI
- 10.1016/0002-9343(90)90388-T · DOI
- 10.1001/archneur.1980.00500590061010 · DOI
- 10.1002/1531-8249(200006)47:6<765::AID-ANA9>3.0.CO;2-8 · DOI
- 10.1212/WNL.31.12.1530 · DOI
- Dyck PJ, 1975, Chronic inflammatory polyradiculoneuropathy, Mayo Clin Proc, 50, 621
- 10.1136/jnnp.45.10.866 · DOI
- 10.1093/brain/110.6.1617 · DOI
- 10.1136/jnnp.60.2.185 · DOI
- 10.1002/mus.880050610 · DOI
- 10.1016/S0140-6736(79)90276-9 · DOI
- 10.1016/S0140-6736(79)92423-1 · DOI
- 10.1056/NEJM198602203140801 · DOI
- 10.1093/brain/119.4.1055 · DOI
- 10.1212/WNL.39.3.422 · DOI
- 10.1002/ana.410300119 · DOI
- 10.1212/WNL.40.2.209 · DOI
- 10.1093/brain/119.4.1067 · DOI
- 10.1002/ana.410360607 · DOI
- Choudhary PP, 1995, Long‐term treatment of chronic inflammatory demyelinating polyradiculoneuropathy with plasma exchange or intravenous immunoglobulin, Q J Med, 88, 493
- 10.1002/ana.1088 · DOI
- 10.1111/j.1600-0897.1996.tb00168.x · DOI
- 10.1002/(SICI)1098-1101(1999)14:3<149::AID-JCA8>3.0.CO;2-9 · DOI
- 10.1111/j.1600-0404.1998.tb00636.x · DOI
- 10.1002/ana.410370705 · DOI
- Yeung KB, 1991, The clinical spectrum of peripheral neuropathies associated with benign monoclonal IgM, IgG and IgA paraproteinaemia, J Neurol, 238, 383, 10.1007/BF00319857 · DOI
- 10.1056/NEJM199111213252105 · DOI
- 10.1002/ana.410270314 · DOI
- 10.1212/WNL.55.9.1256 · DOI
- 10.1136/jnnp.59.3.248 · DOI
- 10.1016/S0165-5728(01)00266-1 · DOI
- 10.1212/WNL.51.6_Suppl_5.S22 · DOI
- 10.1212/WNL.44.11.2028 · DOI
- Azulay JP, 2000, Lower motor neuron disease and signs of dysimmunity, Rev Neurol (Paris), 156, 372
- 10.1056/NEJM199805283382207 · DOI
- Dalakas MC, 1996, Neuropathies in HIV infection, Baillieres Clin Neurol, 5, 199
- 10.1002/jca.2920040103 · DOI
Cited by
Sorted by citations
Rejuvenation of three germ layers tissues by exchanging old blood plasma with saline-albumin
Mehdipour, M., Skinner, C., Wong, N., Lieb, M., Liu, C., Etienne, J., Kato, C., Kiprov, D., Conboy, M. J., & Conboy, I. M. (2020) · Aging · doi:10.18632/aging.103418 · Cited by 115
Self-citation
Metadata
- Authors
- Kiprov, D. D., & Hofmann, J. C.
- Venue
- Therapeutic Apheresis and Dialysis
- Publisher
- Wiley
- Published
- 2003-04
- Volume
- 7
- Issue
- 2
- Pages
- 189-196
- ISSN
- 1744-9979
- 1744-9987
- Cited by
- 13
- References
- 0
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
